Advertisement
Home »

Cost-utility analysis of tapering strategies of biologicals in rheumatoid arthritis patients in the Netherlands.

Jul 10, 2023

ABOUT THE EXPERTS

  • Luuk van Esveld

    Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands.

    Juul M Cox

    Hospital Pharmacy, Maasstad Hospital, Rotterdam, The Netherlands coxj@maasstadziekenhuis.nl.

    Clinical Pharmacology and Toxicology, MaasstadLab Maasstad Hospital, Rotterdam, The Netherlands.

    Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.

    T Martijn Kuijper

    Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands.

    Tessa M Bosch

    Hospital Pharmacy, Maasstad Hospital, Rotterdam, The Netherlands.

    Clinical Pharmacology and Toxicology, MaasstadLab Maasstad Hospital, Rotterdam, The Netherlands.

    Angelique Eam Weel-Koenders

    Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands.

    Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement